Using different high-throughput methods and gold-standard qRT-PCR, we determined the alterations of several immune-related genes, including STAT1, STAT3, and PD-L1, after treatment of the HNSCC cell lines with epigenetic agents. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.